Know Cancer

forgot password

Non-contact Imaging Device (Camera) Can Help Improve Treatment for Patients With Basal Cell Carcinoma.

Phase 1
18 Years
Not Enrolling
Skin Cancer

Thank you

Trial Information

Non-contact Imaging Device (Camera) Can Help Improve Treatment for Patients With Basal Cell Carcinoma.

The current standard of care for skin cancer is excision, curettage and electrodesiccation
and/or cryosurgery. These methods result in scarring, whereas PDT, on the other hand,
offers the potential for enhanced treatment with less scarring. In spite of this advantage
that PDT has over current techniques, it has still not achieved the consistent performance
required to gain clinical acceptance.

The researchers want to use an imaging system that can characterize the tissue and
photosensitizer optical properties and use that information to drive a treatment light
projection system that can spatially optimize the light irradiance for personalized
treatment, thus improving outcomes.

Inclusion Criteria:

- Age > 18 years

- Biopsy proven diagnosis of a basal cell carcinoma in a non-facial area

Exclusion Criteria:

- Age < 18 years

- Pregnancy

- Breast feeding.

- photosensitivity

Type of Study:


Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care

Outcome Measure:

To determine if non-contact optical imaging device called Modulated Imaging (MI), can help us customize PDT treatment for patients with skin cancer.

Outcome Time Frame:

4 weeks

Safety Issue:


Principal Investigator

Kristen M Kelly, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Beckman Laser Institute University of California Irvine


United States: Institutional Review Board

Study ID:




Start Date:

October 2008

Completion Date:

September 2012

Related Keywords:

  • Skin Cancer
  • Skin Neoplasms



Beckman Laser Institute Medical clinic Irvine, California  92612